BioSpace News Archive

FDA

Fallout Continues as Third FDA Panel Member Resigns Over Aduhelm Approval

Aaron Kesselheim, a professor of Medicine at Harvard Medical School and has served on the advisory committee since 2015, has stepped down.

June 11, 2021
·
4 min read
·
Mark Terry
Genetown

Could Elemental Metals Be Key to Effective Alzheimer’s Treatments?

This is the first confirmation of elemental metals in human brain tissue. Researchers hope it can contribute to the ongoing Herculean task of finding a cure for Parkinson’s and Alzheimer’s.

June 11, 2021
·
3 min read
·
Kate Goodwin
FDA

FDA Action Alert: Blueprint, Orphazyme and Eton

The month of June continues to be busy for the U.S. Food and Drug Administration. There are three PDUFA dates on the calendar for this week. Here’s a look.

June 11, 2021
·
3 min read
·
Mark Terry
Drug Development

EHA Updates: Companies Share Positive Data in Different Blood Disorders

The 2021 EHA is in full swing. BioSpace is rounding up several presentations from the past two days. Here are some of them.

June 11, 2021
·
5 min read
·
Alex Keown
BioMidwest

Clinical Catch-Up: June 7-11

A busy week for clinical trial news as the ASCO meeting wrapped up and the European Hematology Association 2021 Virtual Congress began. Read on for more.

June 11, 2021
·
15 min read
·
Mark Terry
Drug Development

Vertex Falls After Announcing Key Asset for Rare Disease Will Not Advance

Shares of Vertex fell more than 13% in premarket trading after it announced that it will not advance a novel small molecule corrector of the Z-AAT protein into a Phase III study.

June 11, 2021
·
2 min read
·
Alex Keown
Business

G7 Leaders Pledge One Billion COVID-19 Vaccines For Nations in Need

Half of these doses will be shared by the U.S., while the U.K. has committed another 100 million shots.

June 11, 2021
·
2 min read
·
Brandon May
Drug Development

BeiGene Presents Positive Data in Various Lymphomas at EHA2021

Beigene presented results from three pivotal trials at the 26th EHA2021 Virtual Congress for the effectiveness of their checkpoint inhibitor tislelizumab in relapsed or refractory lymphoma.

June 11, 2021
·
3 min read
·
Mark Terry
10 Neuroscience Jobs in High Demand

Whether you’re a seasoned neuroscience professional or thinking about breaking into this field, check out our list of neuroscience jobs in high demand to help with your job search.

June 11, 2021
·
2 min read
·
Lorenzo Soliman
Drug Development

New Data Shows AbbVie’s VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment

The data were presented for the first time today during the virtual 26th European Hematology Association Annual Congress.

June 11, 2021
·
15 min read